Jane Street’s Putnam BioRevolution ETF SYNB Stock Holding History

Jane Street’s Portfolio SYNB Stock Details SYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,326	Closed	-$766K	–	10056
2023 Q4	$766K	Buy	26,326 +15,149	+136%	+$406K	﹤0.01%	6045
2023 Q3	$299K	Buy	11,177 +3,555	+47%	+$99K	﹤0.01%	7069
2023 Q2	$211K	Buy	+7,622	New	+$209K	﹤0.01%	7619

Other funds holding SYNB

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's SYNB Position: Q1 2024 in Review

Jane Street sold out of Putnam BioRevolution ETF (SYNB) in Q1 2024, closing a stake of 26,326 shares — an estimated $766K sold.

Jane Street first reported a position in SYNB in Q2 2023 and held it in 3 quarters. The position peaked at $766K in Q4 2023. 3 funds tracked by Wall St. Rank hold SYNB as of Q1 2024.

Jane Street reported no remaining Putnam BioRevolution ETF position as of Q1 2024 after selling out during the quarter.
Jane Street sold 26,326 Putnam BioRevolution ETF shares in Q1 2024, an estimated $766K.
Jane Street first reported a position in Putnam BioRevolution ETF in Q2 2023 and held it in 3 quarters.
Jane Street's Putnam BioRevolution ETF position peaked at $766K in Q4 2023.
3 funds tracked by Wall St. Rank held Putnam BioRevolution ETF as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.